Dopaminergic dysregulation in prefrontal cortex of rhesus monkeys following cocaine self-administration

Frontiers in Psychiatry

Volumn 4, Issue AUG, 2013, Pages

  McIntosh, Scot ^a   Howell, Leonard ^b,c   Hemby, Scott E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anterior cingulate cortex; Cocaine; Dopamine; Dorsolateral prefrontal cortex; Orbitofrontal cortex; Rhesus monkey

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; POSTSYNAPTIC DENSITY PROTEIN 95; SPINOPHILIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; BRAIN REGION; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; DRUG SELF ADMINISTRATION; ENZYME PHOSPHORYLATION; MALE; NONHUMAN; ORBITAL CORTEX; PREFRONTAL CORTEX; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RHESUS MONKEY; SIGNAL TRANSDUCTION;

EID: 84884467900     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2013.00088     Document Type: Article

References (94)

1. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 85:5274-8. doi:10.1073/pnas.85.14.5274
2. Elliott R, Dolan RJ, Frith CD. Dissociable functions in the medial and lateral orbitofrontal cortex: evidence from human neuroimaging studies. Cereb Cortex (2000) 10:308-17. doi:10.1093/cercor/10.3.308
3. Elliott R, Friston KJ, Dolan RJ. Dissociable neural responses in human reward systems. J Neurosci (2000) 20:6159-65
4. Goldstein RZ, Volkow ND. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry (2002) 159:1642-52. doi:10.1176/appi.ajp.159.10.1642
5. Thorpe SJ, Rolls ET, Maddison S. The orbitofrontal cortex: neuronal activity in the behaving monkey. Exp Brain Res (1983) 49:93-115. doi:10.1007/BF00235545
6. Volkow ND, Ding YS, Fowler JS, Wang GJ. Cocaine addiction: hypothesis derived from imaging studies with PET. J Addict Dis (1996) 15:55-71. doi:10.1300/J069v15n04_04
7. Volkow ND, Fowler JS, Wang GJ. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol (1999) 13:337-45. doi:10.1177/026988119901300406
8. Goldstein RZ, Volkow ND, Wang GJ, Fowler JS, Rajaram S. Addiction changes orbitofrontal gyrus function: involvement in response inhibition. Neuroreport (2001) 12:2595-9. doi:10.1097/00001756-200108080-00060
9. Bolla K, Ernst M, Kiehl K, Mouratidis M, Eldreth D, Contoreggi C, et al. Prefrontal cortical dysfunction in abstinent cocaine abusers. J Neuropsychiatry Clin Neurosci (2004) 16:456-64. doi:10.1176/appi.neuropsych.16.4.456
10. Bolla KI, Eldreth DA, London ED, Kiehl KA, Mouratidis M, Contoreggi C, et al. Orbitofrontal cortex dysfunction in abstinent cocaine abusers performing a decision-making task. Neuroimage (2003) 19:1085-94. doi:10.1016/S1053-8119(03)00113-7
11. Kubler A, Murphy K, Garavan H. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci (2005) 21:1984-92. doi:10.1111/j.1460-9568.2005.04027.x
12. Goldstein RZ, Tomasi D, Alia-Klein N, Zhang L, Telang F, Volkow ND. The effect of practice on a sustained attention task in cocaine abusers. Neuroimage (2007) 35:194-206. doi:10.1016/j.neuroimage.2006.12.004
13. Meade CS, Conn NA, Skalski LM, Safren SA. Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. J Behav Med (2011) 34:128-38. doi:10.1007/s10865-010-9293-5
14. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, et al. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry (1998) 155:124-6
15. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP. Limbic activation during cue-induced cocaine craving. Am J Psychiatry (1999) 156:11-8
16. Garavan H, Pankiewicz J, Bloom A, Cho JK, Sperry L, Ross TJ, et al. Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 157:1789-98. doi:10.1176/appi.ajp.157.11.1789
17. Wexler BE, Gottschalk CH, Fulbright RK, Prohovnik I, Lacadie CM, Rounsaville BJ, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry (2001) 158:86-95. doi:10.1176/appi.ajp.158.1.86
18. Goldstein RZ, Alia-Klein N, Tomasi D, Zhang L, Cottone LA, Maloney T, et al. Is decreased prefrontal cortical sensitivity to monetary reward associated with impaired motivation and self-control in cocaine addiction? Am J Psychiatry (2007) 164:43-51. doi:10.1176/appi.ajp.164.1.43
19. Preuss TM. The discovery of cerebral diversity: an unwelcome scientific revolution. In: Falk D, Gibson K editors. Evolutionary Anatomy of the Primate Cerebral Cortex. Cambridge: Cambridge University Press (2001). p. 138-64.
20. Hemby SE, Tang W, Muly EC, Kuhar MJ, Howell L, Mash DC. Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates. J Neurochem (2005) 95:1785-93. doi:10.1111/j.1471-4159.2005.03517.x
21. Tannu NS, Howell LL, Hemby SE. Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry (2010) 15:185-203. doi:10.1038/mp.2008.53
22. Tannu N, Mash DC, Hemby SE. Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry (2007) 12:55-73. doi:10.1038/sj.mp.4001914
23. Goldman-Rakic PS. Cellular and circuit basis of working memory in prefrontal cortex of nonhuman primates. Prog Brain Res (1990) 85:325-35. discussion 335-326. doi:10.1016/S0079-6123(08)62688-6
24. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science (1979) 205:929-32. doi:10.1126/science.112679
25. Sawaguchi T, Goldman-Rakic PS. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science (1991) 251:947-50. doi:10.1126/science.1825731
26. Jentsch JD, Redmond DE Jr, Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science (1997) 277:953-5. doi:10.1126/science.277.5328.953
27. Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain (1990) 113(Pt 3):617-37. doi:10.1093/brain/113.3.617
28. Taylor JR, Roth RH, Sladek JR Jr, Redmond DE Jr. Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier. Behav Neurosci (1990) 104:564-76. doi:10.1037/0735-7044.104.4.564
29. Lewis DA, Campbell MJ, Foote SL, Goldstein M, Morrison JH. The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. J Neurosci (1987) 7:279-90
30. Levitt P, Rakic P, Goldman-Rakic P. Region-specific distribution of catecholamine afferents in primate cerebral cortex: a fluorescence histochemical analysis. J Comp Neurol (1984) 227:23-36. doi:10.1002/cne.902270105
31. Williams SM, Goldman-Rakic PS. Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex (1998) 8:321-45. doi:10.1093/cercor/8.4.321
32. Goldman-Rakic PS, Lidow MS, Smiley JF, Williams MS. The anatomy of dopamine in monkey and human prefrontal cortex. J Neural Transm Suppl (1992) 36:163-77
33. Torres GE, Carneiro A, Seamans K, Fiorentini C, Sweeney A, Yao WD, et al. Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem (2003) 278:2731-9. doi:10.1074/jbc.M201926200
34. Li LB, Chen N, Ramamoorthy S, Chi L, Cui XN, Wang LC, et al. The role of N-glycosylation in function and surface trafficking of the human dopamine transporter. J Biol Chem (2004) 279:21012-20. doi:10.1074/jbc.M311972200
35. Grimm JW, Shaham Y, Hope BT. Effect of cocaine and sucrose withdrawal period on extinction behavior, cue-induced reinstatement, and protein levels of the dopamine transporter and tyrosine hydroxylase in limbic and cortical areas in rats. Behav Pharmacol (2002) 13:379-88. doi:10.1097/00008877-200209000-00011
36. Trulson ME, Ulissey MJ. Chronic cocaine administration decreases dopamine synthesis rate and increases [3H] spiroperidol binding in rat brain. Brain Res Bull (1987) 19:35-8. doi:10.1016/0361-9230(87)90162-6
37. Beitner-Johnson D, Nestler EJ. Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions. J Neurochem (1991) 57:344-7. doi:10.1111/j.1471-4159.1991.tb02133.x
38. Vrana SL, Vrana KE, Koves TR, Smith JE, Dworkin SI. Chronic cocaine administration increases CNS tyrosine hydroxylase enzyme activity and mRNA levels and tryptophan hydroxylase enzyme activity levels. J Neurochem (1993) 61:2262-8. doi:10.1111/j.1471-4159.1993.tb07468.x
39. Sorg BA, Chen SY, Kalivas PW. Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. J Pharmacol Exp Therap (1993) 266:424-30.
40. Todtenkopf MS, Stellar JR. Assessment of tyrosine hydroxylase immunoreactive innervation in five subregions of the nucleus accumbens shell in rats treated with repeated cocaine. Synapse (2000) 38:261-70. doi:10.1002/1098-2396(20001201)38:3<261::AID-SYN5>3.0.CO;2-E
41. Masserano JM, Baker I, Natsukari N, Wyatt RJ. Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms. Neurosci Lett (1996) 217:73-6. doi:10.1016/0304-3940(96)13047-0
42. Kansy JW, Daubner SC, Nishi A, Sotogaku N, Lloyd MD, Nguyen C, et al. Identification of tyrosine hydroxylase as a physiological substrate for Cdk5. J Neurochem (2004) 91:374-84. doi:10.1111/j.1471-4159.2004.02723.x
43. Edwards S, Graham DL, Bachtell RK, Self DW. Region-specific tolerance to cocaine-regulated cAMP-dependent protein phosphorylation following chronic self-administration. Eur J Neurosci (2007) 25:2201-13. doi:10.1111/j.1460-9568.2007.05473.x
44. Zhai H, Li Y, Wang X, Lu L. Drug-induced alterations in the extracellular signal-regulated kinase (ERK) signalling pathway: implications for reinforcement and reinstatement. Cell Mol Neurobiol (2008) 28:157-72. doi:10.1007/s10571-007-9240-3
45. Haycock JW, Ahn NG, Cobb MH, Krebs EG. ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc Natl Acad Sci U S A (1992) 89:2365-9. doi:10.1073/pnas.89.6.2365
46. Howell LL, Wilcox KM. Intravenous drug self-administration in nonhuman primates. In: Buccafusco JJ editor. Methods of Behavior Analysis in Neuroscience. Boca Raton, FL: CRC Press (2001). p. 91-110.
47. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, et al. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther (2004) 309:959-69. doi:10.1124/jpet.103.060293
48. Henry PK, Howell LL. Cocaine-induced reinstatement during limited and extended drug access conditions in rhesus monkeys. Psychopharmacology (Berl) (2009) 204:523-9. doi:10.1007/s00213-009-1485-8
49. Hemby SE, O'Connor JA, Acosta G, Floyd D, Anderson N, McCool BA, et al. Ethanol-induced regulation of GABA-A subunit mRNAs in prefrontal fields of cynomolgus monkeys. Alcohol Clin Exp Res (2006) 30:1978-85. doi:10.1111/j.1530-0277.2006.00254.x
50. Carmichael ST, Price JL. Architectonic subdivision of the orbital and medial prefrontal cortex in the macaque monkey. J Comp Neurol (1994) 346:366-402. doi:10.1002/cne.903460305
51. Hemby SE, Horman B, Tang W. Differential regulation of ionotropic glutamate receptor subunits following cocaine self-administration. Brain Res (2005) 1064:75-82. doi:10.1016/j.brainres.2005.09.051
52. Tang W-X, Fasulo WH, Mash DC, Hemby SE. Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem (2003) 85:911-24. doi:10.1046/j.1471-4159.2003.01740.x
53. Noel X, Brevers D, Bechara A. A neurocognitive approach to understanding the neurobiology of addiction. Curr Opin Neurobiol (2013) 23:632-8. doi:10.1016/j.conb.2013.01.018
54. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, et al. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry (1991) 148:621-6.
55. Goldstein RZ, Leskovjan AC, Hoff AL, Hitzemann R, Bashan F, Khalsa SS, et al. Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex. Neuropsychologia (2004) 42:1447-58. doi:10.1016/j.neuropsychologia.2004.04.002
56. Tumeh SS, Nagel JS, English RJ, Moore M, Holman BL. Cerebral abnormalities in cocaine abusers: demonstration by SPECT perfusion brain scintigraphy. Work in progress. Radiology (1990) 176:821-4
57. Adinoff B, Devous MD Sr, Cooper DB, Best SE, Chandler P, Harris T, et al. Resting regional cerebral blood flow and gambling task performance in cocaine-dependent subjects and healthy comparison subjects. Am J Psychiatry (2003) 160:1892-4. doi:10.1176/appi.ajp.160.10.1892
58. Tucker KA, Potenza MN, Beauvais JE, Browndyke JN, Gottschalk PC, Kosten TR. Perfusion abnormalities and decision making in cocaine dependence. Biol Psychiatry (2004) 56:527-30. doi:10.1016/j.biopsych.2004.06.031
59. Miyake A, Emerson MJ, Friedman NP. Assessment of executive functions in clinical settings: problems and recommendations. Semin Speech Lang (2000) 21:169-83. doi:10.1055/s-2000-7563
60. Kaufman JN, Ross TJ, Stein EA, Garavan H. Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci (2003) 23:7839-43.
61. Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, et al. Widespread disruption in brain activation patterns to a working memory task during cocaine abstinence. Brain Res (2007) 1171:83-92. doi:10.1016/j.brainres.2007.06.102
62. Hester R, Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci (2004) 24:11017-22. doi:10.1523/JNEUROSCI.3321-04.2004
63. Henry PK, Murnane KS, Votaw JR, Howell LL. Acute brain metabolic effects of cocaine in rhesus monkeys with a history of cocaine use. Brain Imaging Behav (2010) 4:212-9. doi:10.1007/s11682-010-9100-5
64. Lyons D, Friedman DP, Nader MA, Porrino LJ. Cocaine alters cerebral metabolism within the ventral striatum and limbic cortex of monkeys. J Neurosci (1996) 16:1230-8. Pubmed
65. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci (2004) 24:3554-62. doi:10.1523/JNEUROSCI.5578-03.2004
66. Porrino LJ, Lyons D, Miller MD, Smith HR, Friedman DP, Daunais JB, et al. Metabolic mapping of the effects of cocaine during the initial phases of self-administration in the nonhuman primate. J Neurosci (2002) 22:7687-94.
67. Gebhard R, Zilles K, Schleicher A, Everitt BJ, Robbins TW, Divac I. Parcellation of the frontal cortex of the New World monkey Callithrix jacchus by eight neurotransmitter-binding sites. Anat Embryol (Berl) (1995) 191:509-17. doi:10.1007/BF00186741
68. Lewis DA. The catecholaminergic innervation of primate prefrontal cortex. J Neural Transm Suppl (1992) 36:179-200.
69. Ritz MC, Cone EJ, Kuhar MJ. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci (1990) 46:635-45. doi:10.1016/0024-3205(90)90132-B
70. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (1987) 237:1219-23. doi:10.1126/science.2820058
71. Bergman J, Madras BK, Johnson SE, Spealman RD. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther (1989) 251:150-5.
72. Letchworth SR, Nader MA, Smith HR, Friedman DP, Porrino LJ. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci (2001) 21:2799-807.
73. Little KY, Carroll FI, Butts JD. Striatal [125I]RTI-55 binding sites in cocaine-abusing humans. Prog Neuropsychopharmacol Biol Psychiatry (1998) 22:455-66.
74. Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol (2002) 61:436-45. doi:10.1124/mol.61.2.436
75. Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE. Cocaine use increases [3H]WIN 35428 binding sites in human striatum. Brain Res (1993) 628:17-25. doi:10.1016/0006-8993(93)90932-D
76. Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Therap (1994) 271:1678-85.
77. Cesarini L, Alfieri P, Pantaleoni F, Vasta I, Cerutti M, Petrangeli V, et al. Cognitive profile of disorders associated with dysregulation of the RAS/MAPK signaling cascade. Am J Med Genet A (2009) 149A:140-6. doi:10.1002/ajmg.a.32488
78. Adams JP, Sweatt JD. Molecular psychology: roles for the ERK MAP kinase cascade in memory. Annu Rev Pharmacol Toxicol (2002) 42:135-63. doi:10.1146/annurev.pharmtox.42.082701.145401
79. Mazzucchelli C, Vantaggiato C, Ciamei A, Fasano S, Pakhotin P, Krezel W, et al. Knockout of ERK1 MAP kinase enhances synaptic plasticity in the striatum and facilitates striatal-mediated learning and memory. Neuron (2002) 34:807-20. doi:10.1016/S0896-6273(02)00716-X
80. Mazzucchelli C, Brambilla R. Ras-related and MAPK signalling in neuronal plasticity and memory formation. Cell Mol Life Sci (2000) 57:604-11. doi:10.1007/PL00000722
81. Giachello CN, Fiumara F, Giacomini C, Corradi A, Milanese C, Ghirardi M, et al. MAPK/Erk-dependent phosphorylation of synapsin mediates formation of functional synapses and short-term homosynaptic plasticity. J Cell Sci (2010) 123:881-93. doi:10.1242/jcs.056846
82. Feng J, Yan Z, Ferreira A, Tomizawa K, Liauw JA, Zhuo M, et al. Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci U S A (2000) 97:9287-92. doi:10.1073/pnas.97.16.9287 CrossRef Full Text
83. El-Husseini AE, Schnell E, Chetkovich DM, Nicoll RA, Bredt DS. PSD-95 involvement in maturation of excitatory synapses. Science (2000) 290:1364-8.
84. Sweet ES, Previtera ML, Fernandez JR, Charych EI, Tseng CY, Kwon M, et al. PSD-95 alters microtubule dynamics via an association with EB3. J Neurosci (2011) 31:1038-47. doi:10.1523/JNEUROSCI.1205-10.2011
85. Majdi M, Ribeiro-da-Silva A, Cuello AC. Variations in excitatory and inhibitory postsynaptic protein content in rat cerebral cortex with respect to aging and cognitive status. Neuroscience (2009) 159:896-907. doi:10.1016/j.neuroscience.2008.11.034
86. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, et al. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature (1998) 396:433-9. doi:10.1038/24790
87. Beique JC, Andrade R. PSD-95 regulates synaptic transmission and plasticity in rat cerebral cortex. J Physiol (2003) 546:859-67. doi:10.1113/jphysiol.2002.031369
88. Sans N, Petralia RS, Wang YX, Blahos J II, Hell JW, Wenthold RJ. A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci (2000) 20:1260-71.
89. Webster MJ, Elashoff M, Weickert CS. Molecular evidence that cortical synaptic growth predominates during the first decade of life in humans. Int J Dev Neurosci (2011) 29:225-36. doi:10.1016/j.ijdevneu.2010.09.006 CrossRef Full Text
90. Ghasemzadeh MB, Vasudevan P, Giles C, Purgianto A, Seubert C, Mantsch JR. Glutamatergic plasticity in medial prefrontal cortex and ventral tegmental area following extended-access cocaine self-administration. Brain Res (2011) 1413:60-71. doi:10.1016/j.brainres.2011.06.041
91. Kolb B, Pellis S, Robinson TE. Plasticity and functions of the orbital frontal cortex. Brain Cogn (2004) 55:104-15. doi:10.1016/S0278-2626(03)00278-1
92. Fasano C, Bourque MJ, Lapointe G, Leo D, Thibault D, Haber M, et al. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors. Neuropharmacology (2013) 67:432-43. doi:10.1016/j.neuropharm.2012.11.030
93. Yao WD, Gainetdinov RR, Arbuckle MI, Sotnikova TD, Cyr M, Beaulieu JM, et al. Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 41:625-38. doi:10.1016/S0896-6273(04)00048-
94. Robbins TW, Everitt BJ. Neurobehavioural mechanisms of reward and motivation. Curr Opin Neurobiol (1996) 6:228-36. doi:10.1016/S0959-4388(96)80077-8CrossRef Full Text